BF Biosciences Limited (PSX:BFBIO)
130.82
+2.41 (1.88%)
At close: Mar 31, 2026
-21.46% (1Y)
| Market Cap | 11.56B -29.1% |
| Revenue (ttm) | 8.22B +82.0% |
| Net Income | 598.64M +39.9% |
| EPS | 6.78 +8.5% |
| Shares Out | 88.33M |
| PE Ratio | 19.29 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 79,876 |
| Average Volume | 341,065 |
| Open | 131.00 |
| Previous Close | 128.41 |
| Day's Range | 128.56 - 132.00 |
| 52-Week Range | 117.00 - 194.90 |
| Beta | n/a |
| RSI | 40.65 |
| Earnings Date | Apr 28, 2026 |